BlackRock Institutional Trust Company, N.A. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 45 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$41,000
-12.8%
42,0340.0%0.00%
Q3 2016$47,000
-24.2%
42,0340.0%0.00%
Q2 2016$62,000
+3.3%
42,0340.0%0.00%
Q1 2016$60,000
-13.0%
42,0340.0%0.00%
Q4 2015$69,000
-29.6%
42,0340.0%0.00%
Q3 2015$98,000
-14.8%
42,0340.0%0.00%
Q2 2015$115,000
-78.2%
42,034
-73.3%
0.00%
Q1 2015$528,000
-5.0%
157,542
-1.7%
0.00%
Q4 2014$556,000
-35.4%
160,206
-6.5%
0.00%
Q3 2014$861,000
-69.0%
171,258
-14.8%
0.00%
Q2 2014$2,777,000
+3020.2%
201,105
+3371.5%
0.00%
Q1 2014$89,0005,7930.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$222,0000.08%
Geneos Wealth Management Inc. 478,067$626,0000.03%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$16,0000.01%
Atria Wealth Solutions, Inc. 281,700$369,0000.01%
Vivaldi Capital Management LP 17,078$22,0000.01%
OSAIC HOLDINGS, INC. 1,284,481$1,684,0000.00%
Ameritas Advisory Services, LLC 45,302$59,0000.00%
CENTAURUS FINANCIAL, INC. 20,947$27,0000.00%
Summit Trail Advisors, LLC 23,855$31,0000.00%
WEDBUSH SECURITIES INC 27,998$37,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders